China Grand Pharmaceutical and Healthcare Holdings Ltd ($512) - buy or sell? Stock discussion, ideas, forum

China Grand Pharmaceutical and Healthcare Holdings Ltd

China Grand Pharmaceutical and Healthcare Holdings Limited is an investment holding company, its subsidiaries are principally engaged in the development, manufacture and sale of bulk pharmaceuticals, pharmaceutical intermediates and preparations.

Industry: Pharmaceuticals

Ticker	Exchange	ISIN	Name
$512	HKEx Main Board	BMG210A71016	Code: 512

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 512 stock

Share your investment idea or question on China Grand Pharmaceutical and Healthcare Holdings Ltd stock:

Latest twits on China Grand Pharmaceutical and Healthcare Holdings Ltd (512)

No twits yet. Be the first to post!

Have a question about 512? Ask and other investors will be eager to help you.

Have an idea about 512? Share it with other investors.

China Grand Pharmaceutical and Healthcare Holdings Ltd news

27/03/2017 China Grand Pharmaceutical and Healthcare Holdings Ltd reports 48.8% Net Income growth

30/03/2016 China Grand Pharmaceutical and Healthcare Holdings Ltd Debt jumped on 47.7% in 2015 and Revenue increased on 4.0%

China Grand Pharmaceutical and Healthcare Holdings Ltd stock price chart

China Grand Pharmaceutical and Healthcare Holdings Ltd financials

mln. HKD	FY2010	FY2011	FY2012

Revenue	1,055	1,648	2,059
EBITDA	220.4	182.2	231.7
Net income	97.973	54.235	67.305
CAPEX	50.605	287.3	796.4
Debt	406.0	789.8	1,558
Cash	307.0	343.3	304.6